|
Market Closed -
OTC Markets
03:54:41 31/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.0230 USD | -11.88% |
|
-23.33% | -11.54% |
| 05-19 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
Stock exchange
OTC Markets
ADAPY 0.0230 $
-11.88%
13.27K
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| ADAPY | 0.0230USD | -11.88% | 13.27K $ |
Quotes 5-day view: Adaptimmune Therapeutics plc
Delayed Quote OTC Markets
| 26/10/2026 | 27/10/2026 | 28/10/2026 | 29/10/2026 | 30/10/2026 | |
|---|---|---|---|---|---|
| Last | US$0.0251 | US$0.0289 | US$0.0287 | US$0.0261 | US$0.0230 |
| Volume | 340,808 | 43,846 | 45,769 | 144,651 | 576,950 |
| Change | -16.33% | +15.14% | -0.69% | -9.06% | -11.88% |
| Opening | US$0.0250 | US$0.0250 | US$0.0250 | US$0.0287 | US$0.0286 |
| High | US$0.0300 | US$0.0299 | US$0.0289 | US$0.0287 | US$0.0286 |
| Low | US$0.0250 | US$0.0250 | US$0.0250 | US$0.0251 | US$0.0200 |
Performance
| 1 day | -11.88% | ||
| 1 week | -23.33% | ||
| 1 month | -39.47% | ||
| 3 months | -27.67% | ||
| 6 months | +130.00% | ||
| Current year | -11.54% | ||
| 1 year | -54.18% | ||
| 3 years | -95.75% | ||
| 5 years | -99.55% | ||
| 10 years | -99.47% |
Volumes
marketsDaily volume
576,950
Estimated daily volume
576,950
Avg. Volume 20 sessions
185,390
Daily volume ratio
3.11
Avg. Volume 20 sessions USD
4,263.97
Record volume 1
825,386,452
Record volume 2
556,930,770
Record volume 3
516,546,145
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
6,096,186
Net sales (USD)
5,924,000
Number of employees
272
Sales / Employee (USD)
21,779
Free-Float
14.03%
Free-Float capitalization (USD)
5,130,015
Average Daily Capital Traded
0.07%
Indicators
Moving average 5 days
0.0264
Moving average 20 days
0.03
Moving average 50 days
0.0277
Moving average 100 days
0.0304
Price spread / (MMA5)
+14.78%
Price spread / (MMA20)
+30.43%
Price spread / (MMA50)
+20.43%
Price spread / (MMA100)
+32.17%
RSI 9 days
43.26
RSI 14 days
45.62
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -11.88% | -23.33% | -54.18% | -95.75% | 6.1M | |
| +3.19% | +11.31% | +64.28% | +155.91% | 1,263B | |
| -0.73% | +3.56% | +44.65% | +84.17% | 658B | |
| +1.41% | +3.24% | +35.25% | +108.88% | 521B | |
| +0.42% | +3.20% | +55.81% | +72.50% | 391B | |
| +2.18% | +2.93% | +73.90% | +45.59% | 369B | |
| +1.12% | +4.52% | +34.76% | +58.24% | 307B | |
| +6.96% | +8.86% | +11.95% | +36.20% | 290B | |
| +1.15% | +6.09% | +56.15% | +82.25% | 252B | |
| +3.06% | +9.38% | +42.48% | +117.32% | 212B | |
| Average | +0.69% | +2.98% | +36.51% | +66.53% | 426.19B | |
| Weighted average by Cap. | +2.01% | +6.60% | +50.51% | +100.44% |
Historical Quotes: Adaptimmune Therapeutics plc
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
3e1eb8b3a87329.7fLMmVTCIUlTpdW27d2rjNN0wIM2b5Af-LhAQOrlJDg.2LeHqwTzSwph4-f-pu7s-4pBofN9I6lAlu4RA6eEewy6oob_JO9ALmPf7Q
| Date | Price | Volume | Total |
|---|---|---|---|
| 03:54:41 | 0.0230 | 500 | 576,760 |
| 03:54:24 | 0.0230 | 100 | 576,260 |
| 03:53:52 | 0.0230 | 100 | 576,160 |
| 03:53:00 | 0.0205 | 17,000 | 576,060 |
| 03:52:46 | 0.0205 | 10,000 | 559,060 |
| 03:48:11 | 0.0230 | 100 | 549,060 |
| 03:47:32 | 0.0205 | 3,016 | 548,960 |
| 03:47:29 | 0.0220 | 1,000 | 545,944 |
| 03:47:16 | 0.0205 | 163 | 544,944 |
| 03:34:55 | 0.0230 | 100 | 544,781 |
Price Extremes
| 1 week | 0.02 |  | 0.03 |
| 1 month | 0.02 | | 0.04 |
| Current year | 0 | | 0.05 |
| 1 year | 0 | | 0.07 |
| 3 years | 0 | | 2.05 |
| 5 years | 0 | | 5.95 |
| 10 years | 0 | | 14.62 |
Monthly variations
Annual variations
| 2026 | -11.54% | ||
| 2025 | -95.17% | ||
| 2024 | -32.07% | ||
| 2023 | -45.68% | ||
| 2022 | -61.07% | ||
| 2021 | -30.43% | ||
| 2020 | +349.17% | ||
| 2019 | -79.13% | ||
| 2018 | -13.92% | ||
| 2017 | +64.94% | ||
| 2016 | -66.42% | ||
| 2015 | -30.01% |
- Stock Market
- Stocks
- ADAPY Stock
- Quotes Adaptimmune Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
